Skip to main content

Inmune Bio, Inc.

INMB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001711754

No open-market purchases or sales by Inmune Bio, Inc. insiders were filed in the last 90 days; 82 institutions reported holding it in 13F filings for Q2 2026, worth $7.08M in total; no superinvestor holds it.

13F holders, Q3 2022

Institutional positions in Inmune Bio, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
33
−2 vs. Q2 2022
Shares held
1.92M
−99.1K (−4.9%) vs. Q2 2022
Total value
$11.9M
−$5.79M (−32.8%) vs. Q2 2022
New holders
4
9 more added
Sold out
6
8 more reduced

1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting INMB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2022: 33 institutions
Q1 2021: 33 institutionsQ2 2021: 41 institutionsQ3 2021: 41 institutionsQ4 2021: 43 institutionsQ1 2022: 34 institutionsQ2 2022: 36 institutionsQ3 2022: 33 institutionsQ4 2022: 34 institutionsQ1 2023: 35 institutionsQ2 2023: 34 institutionsQ3 2023: 37 institutionsQ4 2023: 48 institutionsQ1 2024: 52 institutionsQ2 2024: 57 institutionsQ3 2024: 67 institutionsQ4 2024: 73 institutionsQ1 2025: 82 institutionsQ2 2025: 79 institutionsQ3 2025: 73 institutionsQ4 2025: 74 institutionsQ1 2026: 82 institutionsQ2 2026: 82 institutions
Value heldQ3 2022: $11.9M
Q1 2021: $15.5MQ2 2021: $30.6MQ3 2021: $37.7MQ4 2021: $25.4MQ1 2022: $19.3MQ2 2022: $17.7MQ3 2022: $11.9MQ4 2022: $10.4MQ1 2023: $11.7MQ2 2023: $18.2MQ3 2023: $14.5MQ4 2023: $25.8MQ1 2024: $32.2MQ2 2024: $40.3MQ3 2024: $28.8MQ4 2024: $29.5MQ1 2025: $48.1MQ2 2025: $12.7MQ3 2025: $9.64MQ4 2025: $7.93MQ1 2026: $6.09MQ2 2026: $7.08M
Institutions holding INMB and their total value by quarter
QuarterHoldersValue
Q2 202682$7.08M
Q1 202682$6.09M
Q4 202574$7.93M
Q3 202573$9.64M
Q2 202579$12.7M
Q1 202582$48.1M
Q4 202473$29.5M
Q3 202467$28.8M
Q2 202457$40.3M
Q1 202452$32.2M
Q4 202348$25.8M
Q3 202337$14.5M
Q2 202334$18.2M
Q1 202335$11.7M
Q4 202234$10.4M
Q3 202233$11.9M
Q2 202236$17.7M
Q1 202234$19.3M
Q4 202143$25.4M
Q3 202141$37.7M
Q2 202141$30.6M
Q1 202133$15.5M

Institutions, Q3 2022

Shares, value and share of portfolio for each institution holding Inmune Bio, Inc.; share changes are against Q2 2022.

Institutions holding INMB in Q3 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Vanguard Group Inc541,398$3.36M0.00%−12,240−2.2%Reduced
BlackRock Inc.233,243$1.45M0.00%−877−0.4%Reduced
Janney Montgomery Scott LLC195,486$1.21M0.01%−15,832−7.5%Reduced
ACT Capital Management, LLC151,100$937.0K1.29%−9,400−5.9%Reduced
Geode Capital Management, LLC139,606$865.0K0.00%+1,382+1.0%Added
Morgan Stanley129,000$800.0K0.00%−79,282−38.1%Reduced
Deutsche Bank AG121,048$750.0K0.00%00.0%Unchanged
Royal Bank of Canada60,528$375.0K0.00%+1,661+2.8%Added
State Street Corp44,963$279.0K0.00%00.0%Unchanged
UBS Group AG39,950$248.0K0.00%+1,000+2.6%Added
Group One Trading, L.P.36,156$224.0K0.01%+2,683+8.0%Added
Westside Investment Management, Inc.30,240$187.0K0.00%+100+0.3%Added
Millennium Management LLC27,169$168.0K0.00%+27,169New
Citadel Advisors LLC26,132$162.0K0.00%+9,469+56.8%Added
Fermata Advisors, LLC24,311$151.0K0.05%+300+1.2%Added
Sepio Capital, LP24,400$151.0K0.01%+2,400+10.9%Added
Susquehanna International Group, LLP23,773$147.0K0.00%+23,773New
Northern Trust Corp19,106$118.0K0.00%00.0%Unchanged
Wells Fargo & Company12,678$78.0K0.00%−949−7.0%Reduced
YorkBridge Wealth Partners, LLC10,369$64.0K0.02%00.0%Unchanged
Advisor Group Holdings, Inc.6,050$38.0K0.00%+493+8.9%Added
Northwestern Mutual Wealth Management Co4,300$27.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)3,909$25.0K0.00%+3,909New
Leonteq Securities AG2,800$17.4K0.00%−1,000−26.3%Reduced
Simplex Trading, LLC2,179$13.0K0.00%−4,113−65.4%Reduced
Bank of America Corp1,858$12.0K0.00%00.0%Unchanged
Valley National Advisers Inc1,000$7.00K0.00%00.0%Unchanged
Covington Capital Management1,000$6.00K0.00%00.0%Unchanged
Asset Dedication, LLC814$5.00K0.00%00.0%Unchanged
Federation des caisses Desjardins du Quebec400$2.48K0.00%00.0%Unchanged
BNP Paribas Arbitrage, SA371$2.30K0.00%+371New
FNY Investment Advisers, LLC250$1.00K0.00%00.0%Unchanged
IFP Advisors, Inc184$1.00K0.00%00.0%Unchanged
Renaissance Technologies LLC0$00.00%−32,100−100.0%Sold out
Financial Advocates Investment Management0$00.00%−15,167−100.0%Sold out
Citigroup Inc0$00.00%−1,300−100.0%Sold out
The PNC Financial Services Group, Inc.0$00.00%−820−100.0%Sold out
High Net Worth Advisory Group LLC0$00.00%−500−100.0%Sold out
Captrust Financial Advisors0$00.00%−269−100.0%Sold out
Cordasco Financial Network––––Not filed